Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization
Authors:
- Hendrik J. KoornhofHKHendrik J. Koornhof
- John B. RobbinsJRJohn B. Robbins
- Nancy N. Le CamNCNancy N. Le Cam
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccinesInfection and Immunity, 1994
- Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccinesVaccine, 1994
- Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid feverVaccine, 1988
- PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVERThe Lancet, 1987
- Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide ofSalmonella TyphiNew England Journal of Medicine, 1987
- Safety and Immunogenicity of Two Salmonella typhi Vi Capsular Polysaccharide VaccinesThe Journal of Infectious Diseases, 1986
- A Quantitative Immunochemical Measure of thePrimary Interaction Between I*BSA and AntibodyThe Journal of Infectious Diseases, 1958